PMH13 CHARACTERISTICS AND COST OUTCOMES OF INSURED PATIENTS TREATED WITH EXTENDED-RELEASE NALTREXONE (XR-NTX) OR ORAL ALCOHOL DEPENDENCE MEDICATIONS
May 1, 2010, 00:00
10.1016/S1098-3015(10)72509-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)72509-2/fulltext
Title :
PMH13 CHARACTERISTICS AND COST OUTCOMES OF INSURED PATIENTS TREATED WITH EXTENDED-RELEASE NALTREXONE (XR-NTX) OR ORAL ALCOHOL DEPENDENCE MEDICATIONS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72509-2&doi=10.1016/S1098-3015(10)72509-2
First page :
Section Title :
Open access? :
No
Section Order :
44